SLI
ALNY icon

Sumitomo Life Insurance’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sumitomo Life Insurance’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$937K Sell
3,111
-173
-5% -$52.2K 0.02% 208
2026
Q1 		$1.09M Buy
3,284
+90
+3% +$30.6K 0.03% 180
2025
Q4 		$1.27M Buy
3,194
+27
+0.9% +$11.9K 0.03% 166
2025
Q3 		$1.44M Buy
3,167
+1,049
+50% +$427K 0.04% 150
2025
Q2 		$691K Buy
+2,118
New +$586K 0.05% 210

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Life Insurance's ALNY Position: Q2 2026 in Review

Sumitomo Life Insurance reduced its Alnylam Pharmaceuticals (ALNY) stake by 5.3% in Q2 2026, selling an estimated $52.2K and leaving 3,111 shares worth $937K. The position accounts for 0.02% of the portfolio, ranked #208.

Sumitomo Life Insurance first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.44M in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Sumitomo Life Insurance held 3,111 shares of Alnylam Pharmaceuticals worth $937K as of Q2 2026.
  • Sumitomo Life Insurance sold 173 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $52.2K.
  • Alnylam Pharmaceuticals made up 0.02% of Sumitomo Life Insurance's portfolio in Q2 2026, its #208 holding.
  • Sumitomo Life Insurance first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Sumitomo Life Insurance's Alnylam Pharmaceuticals position peaked at $1.44M in Q3 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Sumitomo Life Insurance's 13F filing for Q2 2026, filed 12 Aug 2026.